Location History:
- Bethesda, MD (US) (1998 - 2007)
- Bethseda, MD (US) (2009)
Company Filing History:
3 out of 3,540 
1 out of 1,217 
Years Active: 1998-2009
Title: Sofia Patricia Becerra: Innovator in Neurotrophic Factors
Introduction
Sofia Patricia Becerra is a distinguished inventor based in Bethesda, MD (US). She has made significant contributions to the field of neurotrophic factors, holding a total of 4 patents. Her work focuses on the development of therapeutic methods and compositions that have the potential to treat various ocular diseases and nerve injuries.
Latest Patents
One of her latest patents is centered around a purified retinal pigmented epithelium derived neurotrophic factor composition. This invention includes a method for purifying such a factor and a recombinant DNA molecule that encodes the retinal pigmented epithelium derived neurotrophic factor. Additionally, it describes a method for treating tumors, ocular diseases, nerve injuries, and conditions resulting from the activity of serine proteases through the administration of PEDF. Another notable patent involves nucleic acids encoding the neurotrophic protein known as pigment epithelium derived factor (PEDF) and its variants. The effects and uses of these variants on neuronal differentiation, neuron survival, and glial inhibition are also detailed in her work.
Career Highlights
Sofia has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the Department of Health. Her innovative research has positioned her as a key figure in the development of neurotrophic therapies.
Collaborations
Throughout her career, Sofia has collaborated with esteemed colleagues such as Gerald J. Chader and Joyce Tombran-Tink. These partnerships have further enhanced her research and contributions to the field.
Conclusion
Sofia Patricia Becerra is a remarkable inventor whose work in neurotrophic factors has the potential to impact the treatment of various medical conditions. Her patents and collaborations reflect her dedication to advancing scientific knowledge and therapeutic applications.